Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 301–400 of 1,018
Wils, H., Kleinberger, G., Pereson, S., Janssens, J., Capell, A., Van Dam, D., Cuijt, I., Joris, G., De Deyn, P. P., Haass, C., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4043 · Cited by 127
Core features of frontotemporal dementia recapitulated in progranulin knockout mice
Ghoshal, N., Dearborn, J. T., Wozniak, D. F., & Cairns, N. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.029 · Cited by 127
Structure, Function, and Mechanism of Progranulin; the Brain and Beyond
Toh, H., Chitramuthu, B. P., Bennett, H. P. J., & Bateman, A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9569-4 · Cited by 146
TDP-43 Proteinopathies: Neurodegenerative Protein Misfolding Diseases without Amyloidosis
Kwong, L. K., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · Neurosignals · doi:10.1159/000109758 · Cited by 127
van der Zee, J., Van Langenhove, T., Kleinberger, G., Sleegers, K., Engelborghs, S., Vandenberghe, R., Santens, P., Van den Broeck, M., Joris, G., Brys, J., et al. (2011) · Brain · doi:10.1093/brain/awr007 · Cited by 126
Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes
Josephs, K. A., Stroh, A., Dugger, B., & Dickson, D. W. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0547-7 · Cited by 126
Self-citationKovacs, G. G., Majtenyi, K., Spina, S., Murrell, J. R., Gelpi, E., Hoftberger, R., Fraser, G., Crowther, R. A., Goedert, M., Budka, H., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318187a80f · Cited by 125
TDP-43: a novel neurodegenerative proteinopathy
Forman, M. S., Trojanowski, J. Q., & Lee, V. M. ‐. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.08.005 · Cited by 139
A novel deletion in progranulin gene is associated with FTDP-17 and CBS
Benussi, L., Binetti, G. G., Sina, E., Gigola, L., Bettecken, T., Meitinger, T., & Ghidoni, R. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.028 · Cited by 132
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN
Whitwell, J. L., Jack, C. R., Boeve, B. F., Senjem, M. L., Baker, M., Rademakers, R., Ivnik, R. J., Knopman, D. S., Wszolek, Z. K., Petersen, R. C., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000343851.46573.67 · Cited by 126
Self-citationBonelli, R. M., & Cummings, J. L. (2008) · The Neurologist · doi:10.1097/nrl.0b013e31815b0de2 · Cited by 136
The ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim?
Dennissen, F. J. A., Kholod, N., & van Leeuwen, F. W. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.003 · Cited by 144
Almeida, M. R., Macário, M. C., Ramos, L., Baldeiras, I., Ribeiro, M. H., & Santana, I. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.019 · Cited by 125
Troakes, C., Maekawa, S., Wijesekera, L., Rogelj, B., Siklós, L., Bell, C., Smith, B., Newhouse, S., Vance, C., Johnson, L., et al. (2012) · Neuropathology · doi:10.1111/j.1440-1789.2011.01286.x · Cited by 124
Thinking laterally about neurodegenerative proteinopathies
Golde, T. E., Borchelt, D. R., Giasson, B. I., & Lewis, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66029 · Cited by 124
Lee, J.-A., & Gao, F.-B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0924-09.2009 · Cited by 124
TMEM 106B p.T185S regulates TMEM 106B protein levels: implications for frontotemporal dementia
Nicholson, A. M., Finch, N. A., Wojtas, A., Baker, M. C., Perkerson, R. B., Castanedes‐Casey, M., Rousseau, L., Benussi, L., Binetti, G., Ghidoni, R., et al. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12329 · Cited by 124
Self-citationBeckers, J., Tharkeshwar, A. K., & Van Damme, P. (2021) · Autophagy · doi:10.1080/15548627.2021.1872189 · Cited by 124
van der Zee, J., Le Ber, I., Maurer-Stroh, S., Engelborghs, S., Gijselinck, I., Camuzat, A., Brouwers, N., Vandenberghe, R., Sleegers, K., Hannequin, D., et al. (2007) · Human Mutation · doi:10.1002/humu.9484 · Cited by 124
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia
Benussi, A., Padovani, A., & Borroni, B. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00171 · Cited by 123
Feng, J. Q., Guo, F., Jiang, B., Zhang, Y., Frenkel, S. R., Wang, D., Tang, W., Xie, Y., & Liu, C.-J. (2010) · The FASEB Journal · doi:10.1096/fj.09-144659 · Cited by 122
Diagnosis and Management of Behavioral Variant Frontotemporal Dementia
Pressman, P. S., & Miller, B. L. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.006 · Cited by 122
Ferrari, R., Wang, Y., Vandrovcova, J., Guelfi, S., Witeolar, A., Karch, C. M., Schork, A. J., Fan, C. C., Brewer, J. B., International FTD-Genomics Consortium (IFGC), et al. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314411 · Cited by 122
Parkinsonism, movement disorders and genetics in frontotemporal dementia
Baizabal-Carvallo, J. F., & Jankovic, J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.14 · Cited by 121
Valdmanis, P. N., Dupre, N., Bouchard, J.-P., Camu, W., Salachas, F., Meininger, V., Strong, M., & Rouleau, G. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.240 · Cited by 120
Cognition, language, and clinical pathological features of non-Alzheimer's dementias: An overview
Reilly, J., Rodriguez, A. D., Lamy, M., & Neils-Strunjas, J. (2010) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2010.04.011 · Cited by 119
Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar Degeneration
Chen-Plotkin, A. S., Martinez-Lage, M., Sleiman, P. M. A., Hu, W., Greene, R., Wood, E. M., Bing, S., Grossman, M., Schellenberg, G. D., Hatanpaa, K. J., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.53 · Cited by 120
Self-citationLoss of progranulin function in frontotemporal lobar degeneration
Cruts, M., & Broeckhoven, C. V. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.01.004 · Cited by 128
Whitwell, J. L., Boeve, B. F., Weigand, S. D., Senjem, M. L., Gunter, J. L., Baker, M. C., DeJesus‐Hernandez, M., Knopman, D. S., Wszolek, Z. K., Petersen, R. C., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12675 · Cited by 119
Self-citationGalimberti, D., Dell’Osso, B. M., Altamura, A. C., & Scarpini, E. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.028 · Cited by 134
Cellular Effects of Progranulin in Health and Disease
Muynck, L. D., & Damme, P. V. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9553-z · Cited by 120
Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation
Li, H.-Y., Yeh, P.-A., Chiu, H.-C., Tang, C.-Y., & Tu, B. P.-H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023075 · Cited by 119
Pottier, C., Ren, Y., Perkerson, R. B., Baker, M., Jenkins, G. D., van Blitterswijk, M., DeJesus-Hernandez, M., van Rooij, J. G. J., Murray, M. E., Christopher, E., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01962-9 · Cited by 118
Self-citationA neurodegenerative disease mutation that accelerates the clearance of apoptotic cells
Kao, A. W., Eisenhut, R. J., Martens, L. H., Nakamura, A., Huang, A., Bagley, J. A., Zhou, P., de Luis, A., Neukomm, L. J., Cabello, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100650108 · Cited by 117
Pathogenesis of the Tauopathies
Goedert, M., & Spillantini, M. G. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9593-4 · Cited by 139
Davidson, Y. S., Barker, H., Robinson, A. C., Thompson, J. C., Harris, J., Troakes, C., Smith, B., Al-Saraj, S., Shaw, C., Rollinson, S., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-70 · Cited by 116
Self-citationTanaka, Y., Matsuwaki, T., Yamanouchi, K., & Nishihara, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.032 · Cited by 126
Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice
Ghazi-Noori, S., Froud, K. E., Mizielinska, S., Powell, C., Smidak, M., Fernandez de Marco, M., O’Malley, C., Farmer, M., Parkinson, N., Fisher, E. M. C., et al. (2012) · Brain · doi:10.1093/brain/aws006 · Cited by 115
“Mutations in the MAPT gene (Hutton et al., 1998; Poorkaj et al., 1998; Spillantini et al., 1998) encoding the tau protein, in the GRN gene (Baker et al., 2006; Cruts et al., 2006) encoding pro- granulin and in the C9ORF72 gene (Dejesus-Hernandez et al., 2011; Renton et al., 2011) are the most…”
BackgroundFrontotemporal lobar degeneration: current perspectives
Kurz, A., Riedl, L., Mackenzie, I., Förstl, H., & Diehl-Schmid, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s38706 · Cited by 113
Self-citationPallidonigral TDP-43 pathology in Perry syndrome
Wider, C., Dickson, D. W., Stoessl, A. J., Tsuboi, Y., Chapon, F., Gutmann, L., Lechevalier, B., Calne, D. B., Personett, D. A., Hulihan, M., et al. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.07.005 · Cited by 115
Self-citationReduced CSF p-Tau 181 to Tau ratio is a biomarker for FTLD-TDP
Hu, W. T., Watts, K., Grossman, M., Glass, J., Lah, J. J., Hales, C., Shelnutt, M., Van Deerlin, V., Trojanowski, J. Q., & Levey, A. I. (2013) · Neurology · doi:10.1212/01.wnl.0000436625.63650.27 · Cited by 113
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD
Borroni, B., Alberici, A., Cercignani, M., Premi, E., Serra, L., Cerini, C., Cosseddu, M., Pettenati, C., Turla, M., Archetti, S., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.031 · Cited by 114
Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases
Mills, J. D., & Janitz, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.030 · Cited by 136
Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke
Kanazawa, M., Kawamura, K., Takahashi, T., Miura, M., Tanaka, Y., Koyama, M., Toriyabe, M., Igarashi, H., Nakada, T., Nishihara, M., et al. (2015) · Brain · doi:10.1093/brain/awv079 · Cited by 113
Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?
Kodama, L., & Gan, L. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.001 · Cited by 112
Progranulin: A key player in autoimmune diseases
Jian, J., Li, G., Hettinghouse, A., & Liu, C. (2018) · Cytokine · doi:10.1016/j.cyto.2016.08.007 · Cited by 112
Programmed Cell Death During Caenorhabditis elegans Development
Conradt, B., Wu, Y.-C., & Xue, D. (2016) · Genetics · doi:10.1534/genetics.115.186247 · Cited by 112
Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease
Jian, J., Tian, Q.-Y., Hettinghouse, A., Zhao, S., Liu, H., Wei, J., Grunig, G., Zhang, W., Setchell, K. D. R., Sun, Y., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.010 · Cited by 112
Microglial Dysregulation in OCD, Tourette Syndrome, and PANDAS
Frick, L. R., & Pittenger, C. (2016) · Journal of Immunology Research · doi:10.1155/2016/8606057 · Cited by 120
Cruchaga, C., Western, D., Timsina, J., Wang, L., Wang, C., Yang, C., Ali, M., Beric, A., Gorijala, P., Kohlfeld, P., et al. (2023) · doi:10.21203/rs.3.rs-2814616/v1 · Cited by 112
Western, D., Timsina, J., Wang, L., Wang, C., Yang, C., Phillips, B., Wang, Y., Liu, M., Ali, M., Beric, A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01972-8 · Cited by 111
Zhao, Y., Tian, Q., Frenkel, S. R., & Liu, C.-J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.030 · Cited by 115
Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool
Romero-Molina, C., Garretti, F., Andrews, S. J., Marcora, E., & Goate, A. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.015 · Cited by 111
Bai, X.-H., Wang, D.-W., Kong, L., Zhang, Y., Luan, Y., Kobayashi, T., Kronenberg, H. M., Yu, X.-P., & Liu, C.-J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00056-09 · Cited by 110
Snowden, J. S., Adams, J., Harris, J., Thompson, J. C., Rollinson, S., Richardson, A., Jones, M., Neary, D., Mann, D. M., & Pickering-Brown, S. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1074700 · Cited by 111
Self-citationFeng, T., Lacrampe, A., & Hu, F. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02246-3 · Cited by 110
What we know about TMEM106B in neurodegeneration
Nicholson, A. M., & Rademakers, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1610-9 · Cited by 110
Self-citationKoh, J.-Y., Kim, H. N., Hwang, J. J., Kim, Y.-H., & Park, S. E. (2019) · Molecular Brain · doi:10.1186/s13041-019-0439-2 · Cited by 110
Deneubourg, C., Ramm, M., Smith, L. J., Baron, O., Singh, K., Byrne, S., Duchen, M. R., Gautel, M., Eskelinen, E., Fanto, M., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1943177 · Cited by 120
Progranulin: A promising therapeutic target for rheumatoid arthritis
Liu, C.-J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.065 · Cited by 113
Molecular analysis and biochemical classification of TDP-43 proteinopathy
Tsuji, H., Arai, T., Kametani, F., Nonaka, T., Yamashita, M., Suzukake, M., Hosokawa, M., Yoshida, M., Hatsuta, H., Takao, M., et al. (2012) · Brain · doi:10.1093/brain/aws230 · Cited by 110
Self-citationUntangling the tau gene association with neurodegenerative disorders
Pittman, A. M., Fung, H.-C., & de Silva, R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl190 · Cited by 110
Boeve, B. F., Baker, M., Dickson, D. W., Parisi, J. E., Giannini, C., Josephs, K. A., Hutton, M., Pickering-Brown, S. M., Rademakers, R., Tang-Wai, D., et al. (2006) · Brain · doi:10.1093/brain/awl268 · Cited by 110
Self-citationSuárez‐Calvet, M., Capell, A., Araque Caballero, M. Á., Morenas‐Rodríguez, E., Fellerer, K., Franzmeier, N., Kleinberger, G., Eren, E., Deming, Y., Piccio, L., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809712 · Cited by 109
“Similarly, haploinsufficiency of PGRN causes FTD (Baker et al, 2006; Cruts et al, 2006), and a complete loss of PGRN results in a lysosomal storage disorder with severe neurodegeneration (Smith et al, 2012; Götzl et al, 2014).”
BackgroundInfluentialXu, J., Xilouri, M., Bruban, J., Shioi, J., Shao, Z., Papazoglou, I., Vekrellis, K., & Robakis, N. K. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.017 · Cited by 108
Holler, C. J., Taylor, G., McEachin, Z. T., Deng, Q., Watkins, W. J., Hudson, K., Easley, C. A., Hu, W. T., Hales, C. M., Rossoll, W., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0114-3 · Cited by 108
The lysosomal protein cathepsin L is a progranulin protease
Lee, C. W., Stankowski, J. N., Chew, J., Cook, C. N., Lam, Y.-W., Almeida, S., Carlomagno, Y., Lau, K.-F., Prudencio, M., Gao, F.-B., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0196-6 · Cited by 107
Self-citationDementia and cognitive impairment in amyotrophic lateral sclerosis: a review
Giordana, M. T., Ferrero, P., Grifoni, S., Pellerino, A., Naldi, A., & Montuschi, A. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0439-6 · Cited by 124
Progranulin is a chemoattractant for microglia and stimulates their endocytic activity
Pickford, F., Marcus, J., Camargo, L. M., Xiao, Q., Graham, D., Mo, J.-R., Burkhardt, M., Kulkarni, V., Crispino, J., Hering, H., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.002 · Cited by 107
Self-citationBelcastro, V., Siciliano, V., Gregoretti, F., Mithbaokar, P., Dharmalingam, G., Berlingieri, S., Iorio, F., Oliva, G., Polishchuck, R., Brunetti-Pierri, N., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr593 · Cited by 107
Role of FET proteins in neurodegenerative disorders
Svetoni, F., Frisone, P., & Paronetto, M. P. (2016) · RNA Biology · doi:10.1080/15476286.2016.1211225 · Cited by 115
Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide
Benussi, L., Ghidoni, R., Pegoiani, E., Moretti, D. V., Zanetti, O., & Binetti, G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.008 · Cited by 107
Rojas, J. C., Wang, P., Staffaroni, A. M., Heller, C., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Ljubenkov, P. A., Heuer, H. W., Fong, J. C., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011848 · Cited by 106
Self-citationGeser, F., Robinson, J. L., Malunda, J. A., Xie, S. X., Clark, C. M., Kwong, L. K., Moberg, P. J., Moore, E. M., Van Deerlin, V. M., Lee, V. M.-Y., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.254 · Cited by 108
Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma
Ho, J. C., Ip, Y. C., Cheung, S. T., Lee, Y. T., Chan, K. F., Wong, S. Y., & Fan, S. T. (2008) · Hepatology · doi:10.1002/hep.22191 · Cited by 106
Zheng, Y., Brady, O. A., Meng, P. S., Mao, Y., & Hu, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021023 · Cited by 105
Kalkonde, Y. V., Jawaid, A., Qureshi, S. U., Shirani, P., Wheaton, M., Pinto‐Patarroyo, G. P., & Schulz, P. E. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.011 · Cited by 105
Ward, M. E., Taubes, A., Chen, R., Miller, B. L., Sephton, C. F., Gelfand, J. M., Minami, S., Boscardin, J., Martens, L. H., Seeley, W. W., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140214 · Cited by 105
Huang, M., Modeste, E., Dammer, E., Merino, P., Taylor, G., Duong, D. M., Deng, Q., Holler, C. J., Gearing, M., Dickson, D., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01037-x · Cited by 103
Self-citationHalliday, G., Bigio, E. H., Cairns, N. J., Neumann, M., Mackenzie, I. R. A., & Mann, D. M. A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1030-4 · Cited by 103
Self-citationZinc as a Neuromodulator in the Central Nervous System with a Focus on the Olfactory Bulb
Blakemore, L. J., & Trombley, P. Q. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00297 · Cited by 106
Van Mossevelde, S., van der Zee, J., Gijselinck, I., Engelborghs, S., Sieben, A., Van Langenhove, T., De Bleecker, J., Baets, J., Vandenbulcke, M., Van Laere, K., et al. (2016) · Brain · doi:10.1093/brain/awv358 · Cited by 98
Patterns of microglial cell activation in frontotemporal lobar degeneration
Lant, S. B., Robinson, A. C., Thompson, J. C., Rollinson, S., Pickering‐Brown, S., Snowden, J. S., Davidson, Y. S., Gerhard, A., & Mann, D. M. A. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12092 · Cited by 102
Self-citationSurvival in progressive supranuclear palsy and frontotemporal dementia
Chiu, W. Z., Kaat, L. D., Seelaar, H., Rosso, S. M., Boon, A. J., Kamphorst, W., & van Swieten, J. C. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.195719 · Cited by 102
Prion-like Spreading in Tauopathies
Ayers, J. I., Giasson, B. I., & Borchelt, D. R. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.04.003 · Cited by 101
Multifunctional molecule ERp57: From cancer to neurodegenerative diseases
Hettinghouse, A., Liu, R., & Liu, C.-J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.011 · Cited by 111
Pathological Changes of Tau Related to Alzheimer’s Disease
Chu, D., & Liu, F. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00457 · Cited by 102
The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family
Spina, S., Farlow, M. R., Unverzagt, F. W., Kareken, D. A., Murrell, J. R., Fraser, G., Epperson, F., Crowther, R. A., Spillantini, M. G., Goedert, M., et al. (2008) · Brain · doi:10.1093/brain/awm280 · Cited by 102
Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly
Dickson, D. W., Baker, M., & Rademakers, R. (2010) · Neurodegenerative Diseases · doi:10.1159/000289231 · Cited by 101
Self-citationEarly-onset dementias: diagnostic and etiological considerations
Masellis, M., Sherborn, K., Neto, P., Sadovnick, D. A., Hsiung, G.-Y. R., Black, S. E., Prasad, S., Williams, M., & Gauthier, S. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt197 · Cited by 100
Self-citationFrontotemporal Dementia Caused by CHMP2B Mutations
M. Isaacs, A., Johannsen, P., Holm, I., E. Nielsen, J., & Consortium, F. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563764 · Cited by 99
Progranulin Deficiency Promotes Post-Ischemic Blood–Brain Barrier Disruption
Jackman, K., Kahles, T., Lane, D., Garcia-Bonilla, L., Abe, T., Capone, C., Hochrainer, K., Voss, H., Zhou, P., Ding, A., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4318-13.2013 · Cited by 99
Pao, W. C., Dickson, D. W., Crook, J. E., Finch, N. A., Rademakers, R., & Graff-Radford, N. R. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31820f8f50 · Cited by 98
Self-citationFrontotemporal Lobar Degeneration: A Clinical Approach
Karageorgiou, E., & Miller, B. (2014) · Seminars in Neurology · doi:10.1055/s-0034-1381735 · Cited by 98
Microglia and astrocyte involvement in neurodegeneration and brain cancer
Vandenbark, A. A., Offner, H., Matejuk, S., & Matejuk, A. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02355-0 · Cited by 110
Mouse models of frontotemporal dementia
Roberson, E. D. (2012) · Annals of Neurology · doi:10.1002/ana.23722 · Cited by 97
Progranulin-associated primary progressive aphasia: A distinct phenotype?
Rohrer, J. D., Crutch, S. J., Warrington, E. K., & Warren, J. D. (2010) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.09.017 · Cited by 98
Mutations in progranulin explain atypical phenotypes with variants in MAPT
Pickering-Brown, S. M., Baker, M., Gass, J., Boeve, B. F., Loy, C. T., Brooks, W. S., Mackenzie, I. R. A., Martins, R. N., Kwok, J. B. J., Halliday, G. M., et al. (2006) · Brain · doi:10.1093/brain/awl289 · Cited by 98
Self-citationTREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment
Jay, T. R., von Saucken, V. E., Muñoz, B., Codocedo, J. F., Atwood, B. K., Lamb, B. T., & Landreth, G. E. (2019) · Glia · doi:10.1002/glia.23664 · Cited by 97
Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis
Boland, S., Swarup, S., Ambaw, Y. A., Malia, P. C., Richards, R. C., Fischer, A. W., Singh, S., Aggarwal, G., Spina, S., Nana, A. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33500-9 · Cited by 97
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.